Center-Authored Papers

Filters: Author is Walker, Bruce D  [Clear All Filters]
B
Berger CT, Frahm N, Price DA, Mothe B, Ghebremichael M, Hartman KL, Henry LM, Brenchley JM, Ruff LE, Venturi V et al..  2011.  High-Functional-Avidity Cytotoxic T Lymphocyte Responses to HLA-B-Restricted Gag-Derived Epitopes Associated with Relative HIV Control.. Journal of virology. 85(18):9334-45. Abstract
Brainard DM, Seung E, Frahm N, Cariappa A, Bailey CC, Hart WK, Shin H-S, Brooks SF, Knight HL, Eichbaum Q et al..  2009.  Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice.. Journal of virology. 83(14):7305-21. Abstract
Brockman MA, Chopera DR, Olvera A, Brumme CJ, Sela J, Markle TJ, Martin E, Carlson JM, Le AQ, McGovern R et al..  2012.  Uncommon Pathways of Immune Escape Attenuate HIV-1 Integrase Replication Capacity.. Journal of virology. 86(12):6913-23. Abstract
Burton DR, Ahmed R, Barouch DH, Butera ST, Crotty S, Godzik A, Kaufmann DE, McElrath MJ, Nussenzweig MC, Pulendran B et al..  2012.  A Blueprint for HIV Vaccine Discovery.. Cell host & microbe. 12(4):396-407. Abstract
C
Cohn LB, Silva IT, Oliveira TY, Rosales RA, Parrish EH, Learn GH, Hahn BH, Czartoski JL, McElrath MJ, Lehmann C et al..  2015.  HIV-1 integration landscape during latent and active infection.. Cell. 160(3):420-32. Abstract
H
Havenar-Daughton C, Lindqvist M, Heit A, Wu JE, Reiss SM, Kendric K, Bélanger S, Kasturi SP, Landais E, Akondy RS et al..  2016.  CXCL13 is a plasma biomarker of germinal center activity.. Proceedings of the National Academy of Sciences of the United States of America. Abstract
L
Lederman MM, Cannon PM, Currier JS, June CH, Kiem HP, Kuritzkes DR, Lewin SR, Margolis DM, McCune JM, Mellors JW et al..  2016.  A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"? Pathogens & immunity. 1(1):154-164. Abstract
Leitman EM, Hurst J, Mori M, Kublin J, Ndung'u T, Walker BD, Carlson J, Gray GE, Matthews PC, Frahm N et al..  2016.  Lower Viral Loads and Slower CD4 Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02.. The Journal of infectious diseases. Abstract
M
McElrath MJ, Walker BD.  2012.  Is an HIV vaccine possible? Journal of acquired immune deficiency syndromes (1999). 60 Suppl 2:S41-3. Abstract
P
Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PIW, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M et al..  2010.  The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.. Science (New York, N.Y.). 330(6010):1551-7. Abstract